You are here:

Amgen Ltd

Name SMC ID No Status Sub. Type
 
Anakinra (Kineret®) 05/02 Not Recommended Resubmission
Anakinra (Kineret®) 05/02 Not Recommended Full submission
blinatumomab (Blincyto) 1145/16 Accepted Full submission
carfilzomib (Kyprolis) 1171/16 Not Recommended Resubmission
carfilzomib (Kyprolis) 1242/17 Accepted Full submission
carfilzomib (Kyprolis) 1171/16 Not Recommended Full submission
cinacalcet (Mimpara) 513/08 Not Recommended Non submission
cinacalcet (Mimpara) 271/06 Not Recommended Non submission
cinacalcet (Mimpara) 169/05 Superseded Resubmission
cinacalcet (Mimpara) 169/05 Superseded Full submission
Darbepoetin alfa Sureclick (Aranesp) 265/06 Superseded Non submission
Darbepoetin alfa (Aranesp®) 273/06 Superseded Non submission
denosumab (Prolia) 651/10 Restricted Full submission
denosumab (Prolia) 670/10 Not Recommended Non submission
denosumab (Prolia) 1013/14 Not Recommended Non submission
denosumab (Xgeva) 752 /11 Superseded Non submission
denosumab (Xgeva) 1119/15 Not Recommended Non submission
etelcalcetide (Parsabiv) 1262/17 Not Recommended Full submission
evolocumab (Repatha) 1148/16 Not Recommended Full submission
evolocumab (Repatha) 1148/16 Restricted Resubmission
Palifermin (Kepivance®) 272/06 Not Recommended Non submission
panitumumab (Vectibix) 769/12 Superseded Non submission
panitumumab (Vectibix) 1082/15 Superseded Non submission
panitumumab 20mg/ml concentrate for solution for infusion (Vectibix) 486/08 Superseded Non submission
Pegfilgrastim (Neulasta®) 67/03 Restricted Full submission
romiplostim (Nplate) 553/09 Restricted Full submission
talimogene laherparepvec (Imlygic) 1248/17 Not Recommended Non submission

Back